Research ArticleArticle
Importance of Obtaining Remission for Work Productivity and Activity of Patients with Rheumatoid Arthritis
Dam Kim, Yuko Kaneko and Tsutomu Takeuchi
The Journal of Rheumatology May 2017, jrheum.161404; DOI: https://doi.org/10.3899/jrheum.161404
Dam Kim
From the Division of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. YK has received consultancies, speaking fees, and/or honoraria from AbbVie Inc., Chugai Pharmaceutical Co. Ltd., and Mitsubishi Tanabe Pharma Co. TT has received consultancies, speaking fees, and/or honoraria from Astellas Pharma, Bristol–Myers K.K., Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Mitsubishi Tanabe Pharma Co., Pfizer Japan Inc., Santen Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teijin Pharma Ltd., AbbVie GK, Asahikasei Pharma Corp., Taisho Toyama Pharmaceutical Co. Ltd., SymBio Pharmaceuticals Ltd., Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co. Ltd, Nipponkayaku Co. Ltd, Astra Zeneca K.K., Eli Lilly Japan K.K., and Novartis Pharma K.K. D. Kim, MD, PhD, Division of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, and Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; Y. Kaneko, MD, PhD, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; T. Takeuchi, MD, PhD, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine. Address correspondence to Dr. Y. Kaneko, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan. E-mail: ykaneko@z6.keio.jp. Accepted for publication April 11, 2017.
Yuko Kaneko
From the Division of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. YK has received consultancies, speaking fees, and/or honoraria from AbbVie Inc., Chugai Pharmaceutical Co. Ltd., and Mitsubishi Tanabe Pharma Co. TT has received consultancies, speaking fees, and/or honoraria from Astellas Pharma, Bristol–Myers K.K., Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Mitsubishi Tanabe Pharma Co., Pfizer Japan Inc., Santen Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teijin Pharma Ltd., AbbVie GK, Asahikasei Pharma Corp., Taisho Toyama Pharmaceutical Co. Ltd., SymBio Pharmaceuticals Ltd., Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co. Ltd, Nipponkayaku Co. Ltd, Astra Zeneca K.K., Eli Lilly Japan K.K., and Novartis Pharma K.K. D. Kim, MD, PhD, Division of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, and Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; Y. Kaneko, MD, PhD, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; T. Takeuchi, MD, PhD, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine. Address correspondence to Dr. Y. Kaneko, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan. E-mail: ykaneko@z6.keio.jp. Accepted for publication April 11, 2017.
Tsutomu Takeuchi
From the Division of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. YK has received consultancies, speaking fees, and/or honoraria from AbbVie Inc., Chugai Pharmaceutical Co. Ltd., and Mitsubishi Tanabe Pharma Co. TT has received consultancies, speaking fees, and/or honoraria from Astellas Pharma, Bristol–Myers K.K., Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Mitsubishi Tanabe Pharma Co., Pfizer Japan Inc., Santen Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teijin Pharma Ltd., AbbVie GK, Asahikasei Pharma Corp., Taisho Toyama Pharmaceutical Co. Ltd., SymBio Pharmaceuticals Ltd., Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co. Ltd, Nipponkayaku Co. Ltd, Astra Zeneca K.K., Eli Lilly Japan K.K., and Novartis Pharma K.K. D. Kim, MD, PhD, Division of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, and Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; Y. Kaneko, MD, PhD, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; T. Takeuchi, MD, PhD, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine. Address correspondence to Dr. Y. Kaneko, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan. E-mail: ykaneko@z6.keio.jp. Accepted for publication April 11, 2017.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Importance of Obtaining Remission for Work Productivity and Activity of Patients with Rheumatoid Arthritis
Dam Kim, Yuko Kaneko, Tsutomu Takeuchi
The Journal of Rheumatology May 2017, jrheum.161404; DOI: 10.3899/jrheum.161404